Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Europe close: Another soft US jobs report stokes volatility and losses

(Sharecast News) - European equities extended the previous session's sharp falls as another weak reading on US non-farm payrolls sparked talk - rightly or wrongly - of a 'policy error' by that country's central bank.

A few months back, many observers were crowing that the Fed might perhaps not even need to cut rates at all in 2024 and that market pricing for rate cuts coming into 2024 had been too dovish.

Come Friday however and Citi as well as JP Morgan were anticipating 50 basis point rate cuts by the Fed in September and November, whilst other houses had also revised up their rate cut calls.

The pan-regional Stoxx 600 index dropped 2.73% to finish at 497.85, alongside similar-sized falls for German and Italian issues.

Adding to the dour mood, overnight Japan's Nikkei-225 fell almost 6% amid worries about growth and the yen.

Strikingly, the VStoxx volatility gauge surged 35% to 24.519.

Ten-year German government bond yields declined by seven basis points to 2.18%, euro/dollar was above 1.09, gold futures hit an intraday high above $2,500/oz. but failed to claim that psychological level on a weekly basis.

Front-dated Brent meanwhile was off by 2.23% at $77.3 a barrel on the ICE.

In equity markets, chipmakers were battered as Intel slumped 27% after the sector giant suspended its dividend and said it would cut 15% of its workforce in response to retrenched spending on traditional data center semiconductors and a focus on AI chips.

ASM International fell more 13%, while BE Semiconductor was down 9% and ASML by 11%.

IAG jumped 5% after the BA and Iberia owner said it would start paying dividends again, posted a rise in first-half profits and abandoned its pursuit of Air Europa.

GSK rose as it said the US Food and Drug Administration has approved its Jemperli treatment in combination with chemotherapy and then use on its own for adult patients with primary advanced or recurrent endometrial cancer.

Dutch chemical maker and distributor IMCD led the gainers on the Stoxx 600 after better-than-expected second quarter earnings.

Share this article

Related Sharecast Articles

London close: Stocks manage gains ahead of key rate decisions
(Sharecast News) - London stocks closed slightly above the waterline on Monday, as investors exercised caution ahead of key interest rate announcements scheduled across the globe later in the week.
Director dealings: FirstGroup CEO buys shares, Deliveroo chief sells
(Sharecast News) - FirstGroup announced on Monday that its chief executive officer and executive director, Graham Sutherland, had purchased 20,000 shares of the company at 153.4p per share.
Broker tips: Marks & Spencer, JTC
(Sharecast News) - RBC Capital Markets lifted its price target on Marks & Spencer on Monday to 400p from 350p as it raised estimates on the 'outperform' rated stock, pointing to sales momentum and the recent re-rating of the UK food retail sector.
FTSE 100 movers: M&S boosted by broker note; Phoenix slumps
(Sharecast News) - London's FTSE 100 was up 0.2% at 8,285.18 in afternoon trade on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.